Xeris Biopharma Holdings, Inc. (XERS): Shares Outstanding
166.22M
As of 2025-12-31
173.59M
As of 2026-06-30
+6.8%
3-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 166.22M | +11.2% | 2026-03-02, Balance as of period end |
| 2024-12-31 | 149.43M | +8.2% | 2026-03-02, Balance as of period end |
| 2023-12-31 | 138.13M | +1.4% | 2025-03-06, Balance as of period end |
| 2022-12-31 | 136.27M | +9.1% | 2024-03-06, Balance as of period end |
| 2021-12-31 | 124.87M | n/a | 2023-03-08, Balance as of period end |